Your browser doesn't support javascript.
loading
Smell and taste disorders in Spanish patients with mild COVID-19. / Afectación del sentido del olfato y el gusto en la enfermedad leve por coronavirus (COVID-19) en pacientes españoles.
Barón-Sánchez, J; Santiago, C; Goizueta-San Martín, G; Arca, R; Fernández, R.
Afiliación
  • Barón-Sánchez J; Servicio de Neurofisiología Clínica, Complejo Asistencial de Zamora, Zamora, España. Electronic address: mdjohanna.29@gmail.com.
  • Santiago C; Servicio de Neurofisiología Clínica, Complejo Asistencial de Zamora, Zamora, España.
  • Goizueta-San Martín G; Servicio de Neurofisiología, Hospital Santa Cristina, Madrid, España.
  • Arca R; Servizio di Neurologia, Azienda Sanitaria dellAlto Adige, Brunico, Bolzano, Italia.
  • Fernández R; Servicio de Salud Laboral, Complejo Asistencial de Zamora, Zamora, España.
Neurologia (Engl Ed) ; 35(9): 633-638, 2020.
Article en En, Es | MEDLINE | ID: mdl-32900532
INTRODUCTION: Coronavirus disease 2019 (COVID-19) has spread rapidly throughout the world. Smell and/or taste disorders have emerged as a very frequent symptom as the disease has spread in Europe. Spain is one of the European countries with the highest number of infections. OBJECTIVE: This study aimed to investigate the clinical progression of smell and taste disorders in Spanish patients with mild COVID-19. METHODS: An online survey was used to conduct a cross-sectional study of patients who presented sudden smell and/or taste disorders during the 2 months of total lockdown due to COVID-19 in Spain. RESULTS: In our sample, 91.18% of respondents with impaired smell and/or taste and who were able to undergo PCR testing were positive for SARS-CoV-2 infection. Anosmia and ageusia presented in isolation in 6.5% of participants. The remaining 93.5% presented other mild symptoms: headache (51.6%), cough (51.6%), myalgia (45.2%), asthaenia (38.7%), nasal congestion or rhinorrhoea (35.5%), fever (41.9%), low-grade fever (29.0%), odynophagia (25.8%), or diarrhoea (6.5%). The mean duration of anosmia was 8.33 days, with patients subsequently manifesting hyposmia; complete resolution occurred after a mean of 17.79 days. In 22.6% of respondents, olfactory deficits persisted. All participants recovered their sense of taste. CONCLUSIONS: Olfactory and gustatory disorders are prevalent symptoms in mild COVID-19. Most patients do not present associated nasal congestion or rhinorrhoea and a small group of patients present these alterations in isolation.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neumonía Viral / Trastornos del Gusto / Infecciones por Coronavirus / Betacoronavirus / Trastornos del Olfato Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En / Es Revista: Neurologia (Engl Ed) Año: 2020 Tipo del documento: Article Pais de publicación: España

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neumonía Viral / Trastornos del Gusto / Infecciones por Coronavirus / Betacoronavirus / Trastornos del Olfato Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En / Es Revista: Neurologia (Engl Ed) Año: 2020 Tipo del documento: Article Pais de publicación: España